Hemab Therapeutics Presents New Preclinical Research Demonst

/PRNewswire/ -- Hemab Therapeutics, a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding and...

Related Keywords

Montreal , Quebec , Canada , Denmark , Copenhagen , Køavn , Boston , Massachusetts , United States , Viia Fviia , Glanzmann Thrombasthenia , Benny Sorensen , International Society On Thrombosis , European Association For Haemophilia , International Society , Demonstrates Effect , European Association , Allied Disorders , Bernard Soulier Syndrome , Von Willebrand Disease , Hemab Therapeutics ,